Wyeth

  • A Phase III Trial for Locally Advanced or Metastatic Breast Cancer (3144A2-3003) — Breast Cancer Trials
  • <!--[if gte mso 9]> Normal 0 false false false MicrosoftInternetExplorer4 <![endif]--><!--[if gte mso 9]> <![endif]--> <!--{cke_protected}%3C!%2D%2D%0A%20%2F*%20Style%20Definitions%20*%2F%0A%20p.MsoNormal%2C%20li.MsoNormal%2C%20div.MsoNormal%0A%09%7Bmso-style-parent%3A%22%22%3B%0A%09margin%3A0in%3B%0A%09margin-bottom%3A.0001pt%3B%0A%09mso-pagination%3Awidow-orphan%3B%0A%09font-size%3A12.0pt%3B%0A%09font-family%3A%22Times%20New%20Roman%22%3B%0A%09mso-fareast-font-family%3A%22Times%20New%20Roman%22%3B%7D%0A%40page%20Section1%0A%09%7Bsize%3A8.5in%2011.0in%3B%0A%09margin%3A1.0in%201.25in%201.0in%201.25in%3B%0A%09mso-header-margin%3A.5in%3B%0A%09mso-footer-margin%3A.5in%3B%0A%09mso-paper-source%3A0%3B%7D%0Adiv.Section1%0A%09%7Bpage%3ASection1%3B%7D%0A%2D%2D%3E--> <!--[if gte mso 10]> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ansi-language:#0400; mso-fareast-language:#0400; mso-bidi-language:#0400;} <![endif]-->A Phase I/II Trial for Subjects with Solid Tumors and ErbB-2 Positive Met or Locally Advanced Breast Cancer. (3144A1-2206) — Miscellaneous